Not for Dissemination in the US or through US Newswire Services TORONTO, May 21, 2024 RAMM Pharma Corp. , is providing an update on its dispute with Sergio Martines and NATURALE SCIENCE INC. ,.
Sintalica Bioscience Corp. ("Sintalica" or the "Company"), a drug discovery company focused on breakthrough treatments for neuroinflammatory disorders, today announced that the Company has achieved two
Sintalica Bioscience Corp. ("Sintalica" or the "Company"), a psychedelic drug discovery company focused on breakthrough treatments for neuroinflammatory disorders, today announced that the Company has
Company” or
RAMM ) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Company has entered into a definitive acquisition agreement with Canapar Corp. (“
Canapar”) and a wholly-owned subsidiary of the Company on May 11, 2021, that provides for the acquisition of all the common shares of Canapar (“
Canapar Shares”) that the Company does not currently own in exchange for an aggregate of approximately 21,904,095 common shares RAMM at a deemed value of $1.20 per Ramm Share (“
RAMM Shares”) for a total purchase price of approximately $26.2 million (the “
Transaction”).
Based in Italy, Canapar is positioned to become one of Europe s largest vertically integrated cannabis companies. Canapar s state-of-the-art extraction facility is the largest in Europe and has been custom designed to produce active compounds to be used in high-quality pharmaceutical, wellness and cosmetic products from